ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

roche registration gmbh  - risdiplam - muskelatrofi, spinal - andre midler mod forstyrrelser i muskel-skeletsystemet - evrysdi is indicated for the treatment of 5q spinal muscular atrophy (sma) in patients with a clinical diagnosis of sma type 1, type 2 or type 3 or with one to four smn2 copies.

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

roche registration gmbh - mosunetuzumab - lymfom, follikulært - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

ইউরোপীয় ইউনিয়ন - ডেনিশ - EMA (European Medicines Agency)

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - antineoplastiske midler - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

roche a/s - bromazepam - tabletter - 6 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

roche a/s - ribavirin - filmovertrukne tabletter - 200 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

roche a/s - ribavirin - filmovertrukne tabletter - 400 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - kapsler, hårde - 100+25 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

roche a/s - benserazidhydrochlorid, levodopa - kapsler, hårde - 200+50 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

roche pharmaceuticals a/s - benserazidhydrochlorid, levodopa - dispergible tabletter - 100+25 mg

ডেনমার্ক - ডেনিশ - Lægemiddelstyrelsen (Danish Medicines Agency)

roche pharmaceuticals a/s - dornase alfa - inhalationsvæske til nebulisator, opløsning - 1 mg/ml